Service is in preparation Official β release coming soon. Some features are still being adjusted.

Investical Earnings & investing calendar Earnings & investing calendar
/
AAbbVie Inc. logo
ABBVNYSE

AbbVie Inc.

AbbVie Inc.
Loading price data…
Loading price data…
Chart type
Interval
Moving averages
Up/down colors

Share screenshot

Recent & upcoming events

Aug 4
Filing Time TBD
Quarterly report (10-Q) filing due (est.)
Add to Google Calendar
Jul 31
Earnings 9:00
Earnings call (第2四半期)
Add to Google Calendar
Earnings 7:00
Q2 earnings
Add to Google Calendar
Jul 16
Ex-dividend Time TBD
Ex-dividend (predicted) $1.73
Add to Google Calendar
Jul 6
Earnings Time TBD
Q2 earnings
Add to Google Calendar
Apr 29
Earnings Time TBD
Q1 earnings
Add to Google Calendar
Oct 15
Est.
Ex-dividend Time TBD
Ex-dividend (predicted) $1.73
Add to Google Calendar
Oct 30
Est.
Earnings 7:55 approx.
Q3 earnings (predicted)
Add to Google Calendar
2027
Jan 15
Est.
Ex-dividend Time TBD
Ex-dividend (predicted) $1.73
Add to Google Calendar
Jan 29
Est.
Earnings 7:55 approx.
FY earnings (predicted)
Add to Google Calendar
Feb 17
Est.
Filing Time TBD
Annual report (10-K) filing due (est.)
Add to Google Calendar
May 12
Est.
Shareholder meeting Time TBD
Annual meeting (est.)
Add to Google Calendar

KPI highlights

FY25
Revenue $61.16B YoY +8.6%
Operating income $15.07B margin 24.6%
Net income $4.23B YoY -1.2%
EPS $2.37 YoY -1.2%
P/E 111.1× Rich Rough PER guide (a simplified band — fair value varies by industry and growth stage): <10 Cheap / 10–15 Slightly cheap / 15–22 Fair / 22–35 Slightly rich / ≥35 Rich
ROE -129.2% Sign disagrees with net income (may reflect a one-time accounting item)

Quarterly fundamentals

Income & cash flow Unit: $1M
Quarter FY24 Q4FY25 Q1FY25 Q2FY25 Q3FY25 Q4FY26 Q1
Revenue 15,10213,34315,42315,77616,61815,002
Operating income 84.03,9815,7174,5845,8094,734
Net income -23.01,2899411881,815697
Operating CF 387-1,4795,5326,4085,7403,979

Company news

Ownership over time

Share of total shares outstanding (disclosed major holdings + undisclosed)（2013–2026）

機関投資家 69.8%未開示 30.2%20132015201720192021202320252026
機関投資家 69.8%未開示 30.2%13Q114Q215Q316Q418Q119Q220Q321Q423Q124Q225Q426Q1
機関投資家未開示・浮動株

「国内機関」は信託銀行の名義口座（年金・パッシブ・一部海外資本を含む）を集計し、実質保有者へは分解していません。分類は開示名称からの推定です。

Top shareholders — rank & share

BlackRock, Inc. 8.5%BlackRock, Inc.VANGUARD CAPITAL M 6.5%VANGUARD CAPITAL MANAGEMENT LLCSTATE STREET CORP 4.6%STATE STREET CORPVANGUARD PORTFOLIO 2.8%VANGUARD PORTFOLIO MANAGEMENT LLCGEODE CAPITAL MANA 2.6%GEODE CAPITAL MANAGEMENT, LLCMORGAN STANLEY 2.1%MORGAN STANLEYCapital Research G 1.8%Capital Research Global InvestorsBANK OF AMERICA CO 1.4%BANK OF AMERICA CORP /DE/FMR LLC 1.2%FMR LLCNORTHERN TRUST COR 1.2%NORTHERN TRUST CORP20132015201720192021202320252026
BlackRock, Inc. 8.5%BlackRock, Inc.VANGUARD CAPITAL M 6.5%VANGUARD CAPITAL MANAGEMENT LLCSTATE STREET CORP 4.6%STATE STREET CORPVANGUARD PORTFOLIO 2.8%VANGUARD PORTFOLIO MANAGEMENT LLCGEODE CAPITAL MANA 2.6%GEODE CAPITAL MANAGEMENT, LLCMORGAN STANLEY 2.1%MORGAN STANLEYCapital Research G 1.8%Capital Research Global InvestorsBANK OF AMERICA CO 1.4%BANK OF AMERICA CORP /DE/FMR LLC 1.2%FMR LLCNORTHERN TRUST COR 1.2%NORTHERN TRUST CORP13Q114Q215Q316Q418Q119Q220Q321Q423Q124Q225Q426Q1

Top shareholders — actual figures (as of 2026)

Holder Shares held Ratio Source
その他機関投資家（13F 3951社） 464,170,104 26.2% 13F
BlackRock, Inc. 150,698,125 8.5% 13F
VANGUARD CAPITAL MANAGEMENT LLC 114,880,324 6.5% 13F
STATE STREET CORP 81,217,516 4.6% 13F
VANGUARD PORTFOLIO MANAGEMENT LLC 49,523,078 2.8% 13F
GEODE CAPITAL MANAGEMENT, LLC 46,737,581 2.6% 13F
MORGAN STANLEY 38,016,774 2.1% 13F
Capital Research Global Investors 31,254,786 1.8% 13F
BANK OF AMERICA CORP /DE/ 23,936,943 1.4% 13F
FMR LLC 21,762,703 1.2% 13F
NORTHERN TRUST CORP 21,211,382 1.2% 13F
Capital World Investors 15,841,367 0.9% 13F
GOLDMAN SACHS GROUP INC 15,145,279 0.9% 13F
FRANKLIN RESOURCES INC 14,552,069 0.8% 13F
Capital International Investors 14,418,993 0.8% 13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC 14,161,606 0.8% 13F
UBS Group AG 14,051,196 0.8% 13F
Bank of New York Mellon Corp 13,278,161 0.8% 13F
PRICE T ROWE ASSOCIATES INC /MD/ 13,003,989 0.7% 13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 12,967,398 0.7% 13F
Legal & General Group Plc 12,159,427 0.7% 13F
Nuveen, LLC 11,115,159 0.6% 13F
AMERIPRISE FINANCIAL INC 11,068,310 0.6% 13F
Amundi 10,698,095 0.6% 13F
VANGUARD FIDUCIARY TRUST CO 10,199,396 0.6% 13F
RAYMOND JAMES FINANCIAL INC 9,604,349 0.5% 13F

Source：SEC EDGAR（DEF 14A・13D/G・13F）　Classification inferred from disclosed names

F-Score (Piotroski)

4/7 1 of 7 items lack data

Checks financial health against 9 criteria and shows how many are met as a fraction (more ✓ marks is healthier). Items with no data are shown as “—” — they're simply excluded from judgment, not counted against the score.

ROE and related signals above include a period where the sign disagrees with net income due to a one-time accounting item (see the ROE note in the KPI highlights above).

— Positive ROAExcluded from this period due to the net income/ROE sign mismatch N/A
✓ Positive operating cash flow $19.03B
— ROA improved YoYExcluded from this period due to the net income/ROE sign mismatch N/A
✓ Operating CF exceeds net income (accrual quality) OCF $19.03B / net income $4.23B
✗ Equity ratio improved* Substitute for the original “decrease in long-term debt” 2.5% → -2.4%
✓ Current ratio improved 0.66× → 0.67×
✗ No dilution (shares outstanding did not increase) 1,765,354,859 → 1,768,169,012
— Gross margin improved No data
✓ Asset turnover improved 0.42× → 0.46×

This score is reference information based on our own financial metrics. It is NOT a credit rating issued by a credit rating agency under Article 66-27 of the Financial Instruments and Exchange Act, and is NOT investment advice or a recommendation. Make investment decisions at your own responsibility.

Fact checklist

FY25
Equity ratio -2.4%
Current ratio 0.7×
Years of positive operating CF 12 of last 12 yrs
Payout ratio 326%
Latest fiscal year result Profit (net income $4.23B)

Performance history

Last 10 years
$0.0B$15.3B$30.6B$45.9B$61.2B FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

Income & assets

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Revenue 25,63828,21632,75333,26645,80456,19758,05454,31856,33461,160
Operating income 9,3409,5456,38312,98311,36317,92418,11712,7579,13715,075
Ordinary income ——————————
Net income 5,9535,3095,6877,8824,61611,54211,8364,8634,2784,226
Total assets 66,09970,78659,35289,115150,565146,529138,805134,711135,161133,960
Equity 4,6365,097-8,446-8,17213,07615,40817,25410,3603,325-3,270

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Indicators & cash flow

Unit: $1M
Item FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
EPS $3.65$3.31$3.67$5.30$2.73$6.48$6.65$2.73$2.40$2.37
ROE 128.4%104.2%-67.3%-96.5%35.3%74.9%68.6%46.9%128.7%-129.2%
Operating CF 7,0419,96013,42713,32417,58822,77724,94322,83918,80619,030
Investing CF -6,074-274-1,006596-37,557-2,344-623-2,009-20,820-6,643
Financing CF -3,928-5,512-14,39618,708-11,501-19,039-24,803-17,222-5,211-12,724
FCF ————16,79021,99024,24822,06217,83217,816

A “—” means data wasn't available for that period — it's not a display error or an unusual value.

Source: SEC EDGAR (10-K, etc.) (fetched 2026-07-05) *Some metrics supplemented from additional sources

Key financial metrics

Dividend grower ✓

Sector positioning

Relative standing within the sector
Is this information incorrect?

Data provided by Twelve Data